Zobrazeno 1 - 4
of 4
pro vyhledávání: '"David L. Drum"'
Autor:
Yufeng Wang, David L. Drum, Ruochuan Sun, Yida Zhang, Feng Chen, Fengfei Sun, Emre Dal, Ling Yu, Jingyu Jia, Shahrzad Arya, Lin Jia, Song Fan, Steven J. Isakoff, Allison M. Kehlmann, Gianpietro Dotti, Fubao Liu, Hui Zheng, Cristina R. Ferrone, Alphonse G. Taghian, Albert B. DeLeo, Marco Ventin, Giulia Cattaneo, Yongxiang Li, Youssef Jounaidi, Peigen Huang, Cristina Maccalli, Hanyu Zhang, Cheng Wang, Jibing Yang, Genevieve M. Boland, Ruslan I. Sadreyev, LaiPing Wong, Soldano Ferrone, Xinhui Wang
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-17 (2023)
Abstract The poor efficacy of chimeric antigen receptor T-cell therapy (CAR T) for solid tumors is due to insufficient CAR T cell tumor infiltration, in vivo expansion, persistence, and effector function, as well as exhaustion, intrinsic target antig
Externí odkaz:
https://doaj.org/article/cdd6a0e581e24892b09297cc99e43a32
Autor:
Sjoerd P. F. T. Nota, David O. Osei-Hwedieh, David L. Drum, Xinhui Wang, Francesco Sabbatino, Soldano Ferrone, Joseph H. Schwab
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Chondrosarcoma is a common primary bone malignancy whose phenotype increases with its histologic grade. They are relatively resistant to chemotherapy and radiation therapy limiting curative options for disseminated disease. Chondroitin sulfate proteo
Externí odkaz:
https://doaj.org/article/6dec049dbcc848f4bc918df303ea9467
Autor:
Gong Zhang, Yufeng Wang, Bryan C. Fuchs, Wei Guo, David L. Drum, Derek J. Erstad, Baomin Shi, Albert B. DeLeo, Hui Zheng, Lei Cai, Liyuan Zhang, Kenneth K. Tanabe, Xinhui Wang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundSorafenib, a kinase inhibitor, is a standard treatment for advanced hepatocellular carcinoma (HCC) but provides only a limited survival benefit. Disulfiram (DSF), a drug for treating alcoholism and a chelator of copper (Cu), forms a complex
Externí odkaz:
https://doaj.org/article/edfdbb08ad7d4e848639da985e479712
Autor:
Yufeng Wang, David L. Drum, Ruochuan Sun, Yida Zhang, Ling Yu, Lin Jia, Steven J Isakoff, Allison M Kehlmann, Ali Emre Dal, Gianpietro Dotti, Hui Zheng, Cristina R Ferrone, Alphonse G Taghian, Albert B DeLeo, Hanyu Zhang, Youssef Jounaidi, Song Fan, Peigen Huang, Cheng Wang, Jibing Yang, Genevieve M Boland, Ruslan I Sadreyev, LaiPing Wong, Soldano Ferrone, Xinhui Wang
The poor efficacy of chimeric antigen receptor T-cell therapy (CAR T) for solid tumor is due to insufficient CAR T cell tumor infiltration, in vivo expansion, persistence, and effector function, as well as exhaustion, intrinsic target antigen heterog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a499c48d9815aa8d0e489f78a9b31640
https://doi.org/10.21203/rs.3.rs-2595410/v1
https://doi.org/10.21203/rs.3.rs-2595410/v1